New formulation of mental health drug tested for similarity to standard treatment
NCT ID NCT06494397
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a new tablet called VHX-896 works the same as the standard drug iloperidone in 26 adults with schizophrenia or bipolar I disorder. Participants took both versions at different times to compare drug levels in the blood and check for side effects. The goal was to see if VHX-896 could be used as an alternative to iloperidone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VHX-896 (a new formulation of iloperidone)
What this could lead to
If successful, this could show that VHX-896 works the same as iloperidone but may offer a different dosing option for patients.
What could go wrong
This is a small, early-phase study focused on drug levels, not on treating symptoms. It does not prove VHX-896 is better or safer than existing treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanda Investigational Site
Los Alamitos, California, 90720, United States
-
Vanda Investigational Site
Gaithersburg, Maryland, 20877, United States
-
Vanda Investigational Site
Marlton, New Jersey, 08053, United States